Ovarian Cancer Research
Talcum Powder &
Ovarian Cancer:
The Science & Your Rights
Reviewed by: ClaimCheckUSA Medical & Legal TeamLast updated: March 26, 2026Reading time: 9 min
IARC 2024: Talc Now a Group 1 Carcinogen
In 2024, the International Agency for Research on Cancer upgraded talc to a Group 1 carcinogen — the highest classification, meaning it definitely causes cancer in humans. This significantly strengthens all pending talcum powder lawsuits.
Key Research Studies
Harvard Nurses' Health Study (2000)
Finding: Women using talc in the genital area had a 40% increased risk of ovarian cancer
Study size: 78,000+ women
IARC Classification (2006)
Finding: Classified perineal use of talc-based body powder as a Group 2B carcinogen (possibly carcinogenic to humans)
Study size: Global review
Meta-analysis (Penninkilampi & Eslick, 2018)
Finding: Analysis of 24 studies found a 31% increased risk of ovarian cancer with perineal talc use
Study size: 250,000+ women
American Cancer Society Review (2020)
Finding: Acknowledged the association between talc use and ovarian cancer; recommended women avoid perineal talc use
Study size: Multiple studies
IARC Reclassification (2024)
Finding: Upgraded talc to Group 1 carcinogen (definitely causes cancer) based on new evidence
Study size: Global review
Ovarian Cancer Symptoms to Watch For
Abdominal bloating or swelling
One of the most common early symptoms
Pelvic or abdominal pain
Persistent pain that doesn't resolve
Difficulty eating or feeling full quickly
Often dismissed as digestive issues
Urinary urgency or frequency
Needing to urinate more often than usual
Fatigue
Unusual or persistent tiredness
Back pain
Unexplained lower back pain
Changes in bowel habits
Constipation or diarrhoea
Unexplained weight loss
Losing weight without trying
Used Baby Powder and Developed Ovarian Cancer?
Check your eligibility in 60 seconds. Free case evaluation. No fees unless you win.
Check My EligibilityFrequently Asked Questions
Does talcum powder cause ovarian cancer?
The scientific evidence strongly suggests that regular perineal (genital area) use of talc-based body powder increases the risk of ovarian cancer. In 2024, the IARC upgraded talc to a Group 1 carcinogen (definitely causes cancer in humans). Multiple large studies have found a 30–40% increased risk of ovarian cancer in women who regularly used talcum powder in the genital area.
How does talc reach the ovaries?
Talc particles applied to the genital area can travel through the vagina, uterus, and fallopian tubes to reach the ovaries. This pathway has been demonstrated in laboratory studies. Once in the ovaries, talc particles can cause chronic inflammation, which is a known driver of cancer development. Talc particles have been found in ovarian tissue and pelvic lymph nodes of women who used talcum powder.
What is the IARC 2024 talc reclassification?
In 2024, the International Agency for Research on Cancer (IARC) — part of the World Health Organization — upgraded talc from Group 2B (possibly carcinogenic) to Group 1 (definitely carcinogenic to humans) based on sufficient evidence of ovarian cancer causation. This is the highest carcinogen classification and significantly strengthens talcum powder lawsuits.
How many women have filed talcum powder ovarian cancer lawsuits?
Over 60,000 women have filed talcum powder ovarian cancer lawsuits against Johnson & Johnson and other manufacturers. The cases are consolidated in MDL No. 2738 in the District of New Jersey. Individual trial verdicts have reached hundreds of millions of dollars, and J&J has proposed an $8.9 billion global settlement.
What stage of ovarian cancer qualifies for a talcum powder lawsuit?
All stages of ovarian cancer can qualify for a talcum powder lawsuit. Stage I (localised) through Stage IV (metastatic) cases have all been included in successful claims. However, later-stage cancers with more extensive treatment and greater impact on quality of life typically result in higher settlement values.